| Hypertension and its management in the elderly. | |
| | |
MedLine Citation:
|
PMID: 20006792 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Many trials focused on cardiovascular outcomes demonstrate that reduction in blood pressure to levels below 140/90 mm Hg reduce cardiovascular events including stroke and myocardial infarction. There are very few such trials, however, in the elderly cohort, especially among those aged 70 and older. In the few outcome trials that have been completed in this older age group, systolic blood pressures in the range between 140 and 149 mm Hg demonstrate a clear reduction in cardiovascular events. Moreover, among the subgroup that has a vasculature that allows a systolic pressure to go below 140 mm Hg without cognitive side effects, ie, somnolence, memory loss, etc, does even better than those whose blood pressures are in the 140 to 149 mm Hg range. Thus, titration of systolic blood pressure goals in the elderly should strive for a goal of less than 140 mm Hg, and if not achievable without side effects, compromise to below 150 mm Hg. |
| | |
Authors:
|
Basil O Burney; George L Bakris |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Seminars in nephrology Volume: 29 ISSN: 1558-4488 ISO Abbreviation: Semin. Nephrol. Publication Date: 2009 Nov |
Date Detail:
|
Created Date: 2009-12-17 Completed Date: 2010-04-06 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8110298 Medline TA: Semin Nephrol Country: United States |
Other Details:
|
Languages: eng Pagination: 604-9 Citation Subset: IM |
Affiliation:
|
Department of Medicine, Hypertensive Diseases Unit, University of Chicago Pritzker School of Medicine, Chicago, IL 60637, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Aging / physiology* Antihypertensive Agents / therapeutic use* Diet, Carbohydrate-Restricted Diet, Reducing Humans Hypertension / drug therapy*, physiopathology* Risk Reduction Behavior* |
| Chemical | |
Reg. No./Substance:
|
0/Antihypertensive Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Identifying advanced glycation end products as a major source of oxidants in aging: implications for...
Next Document: Disorders of lipid metabolism and chronic kidney disease in the elderly.